BNP Paribas Financial Markets
CLRB icon

BNP Paribas Financial Markets’s Cellectar Biosciences CLRB Stock Holding History

BNP Paribas Financial Markets’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-561
Closed -$5.03K – 5415
2024
Q4 		$5.03K Buy
+561
New +$25.9K ﹤0.01% 4931

Other funds holding CLRB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets's CLRB Position: Q1 2025 in Review

BNP Paribas Financial Markets sold out of Cellectar Biosciences (CLRB) in Q1 2025, closing a stake of 561 shares — an estimated $5.03K sold.

BNP Paribas Financial Markets first reported a position in CLRB in Q4 2024 and held it in 1 quarter. The position peaked at $5.03K in Q4 2024. 32 funds tracked by Wall St. Rank hold CLRB as of Q1 2025.

  • BNP Paribas Financial Markets reported no remaining Cellectar Biosciences position as of Q1 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 561 Cellectar Biosciences shares in Q1 2025, an estimated $5.03K.
  • BNP Paribas Financial Markets first reported a position in Cellectar Biosciences in Q4 2024 and held it in 1 quarter.
  • BNP Paribas Financial Markets's Cellectar Biosciences position peaked at $5.03K in Q4 2024.
  • 32 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q1 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2025, filed 14 May 2025.